Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Brain scans to find links between brain activity and knee replacement outcomes

Official title: Brain Network-based Precision Medicine to Predict Dissatisfaction Following Total Knee Arthroplasty

Run by Ottawa Hospital Research Institute · NCT07464080 · Data updated 2026-11-12

This study uses brain MRI before and after knee replacement to see if patterns of brain activity can predict which patients will be satisfied with their surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorOttawa Hospital Research Institute
Academic / other
Locations1 site (Ottawa, Ontario)
StatusRecruiting
StartedApril 1, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedMarch 11, 2026
Trial IDNCT07464080 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for a primary TKA for osteoarthritis, inflammatory arthritis, or osteonecrosis who can undergo MRI, speak English or French (or have an approved translator), and do not have major neurological disease, cognitive impairment, revision/bilateral TKA, or chronic opioid use.

Probably not a fit

People with major neurological disorders, dementia or cognitive impairment, revision or bilateral TKA, chronic opioid use, or who cannot attend scans at the study site are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses functional MRI to map brain network activity before and after primary total knee arthroplasty (TKA). Researchers will compare pre- and postoperative brain connectivity and link those changes to patient-reported pain, function, and satisfaction. The aim is to identify brain-based markers that could predict who will remain satisfied or dissatisfied after surgery. The work is performed at The Ottawa Hospital and excludes people with major neurological disorders, cognitive impairment, revision or bilateral TKA, or chronic opioid use.

Why it matters

Potential benefit: If successful, the approach could help clinicians predict which patients are at higher risk of poor satisfaction after knee replacement so care can be personalized.

How similar studies have gone: Previous research has linked brain connectivity patterns to chronic pain and some postoperative outcomes, but using fMRI to predict patient satisfaction after TKA is a relatively new approach and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female patients aged 18 years or older
2. Primary TKA
3. Diagnosis of osteoarthritis, inflammatory arthritis, or osteonecrosis

Exclusion Criteria:

1. Inability or refusal to sign informed consent form
2. Non-English or French speaking, and no licensed translator, family member or substitute decision maker available
3. History of major neurological disorders (e.g traumatic brain injury, epilepsy, multiple sclerosis
4. Cognitive impairment or dementia
5. Revision and/or Bilateral TKA
6. Chronic Opioid use

Where it's running

  • The Ottawa Hospital
    Ottawa, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Simon Garceau — The Ottawa Hospital
  • Study coordinator: Sanjula Costa
  • Email: scosta@ohri.ca
  • Phone: 613-737-8899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.